HopeStage
Back to all studies
CompletedNCT06029426

NMRA-335140 study for adults with major depression

About this titleRead the official source — NCT06029426

Researchers compared NMRA-335140 and placebo to find out how the approaches affected depression symptoms in people with depression.

Medication studyAges 18–65United States
The study in practice

Understand this study

What did researchers investigate?

Researchers compared NMRA-335140 and placebo to find out how the approaches affected depression symptoms in people with depression.

Who was this study for?

This study was for people with depression. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.

Listed locations
Huntsville and 63 more locationsSee all locations and recruitment
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: September 20, 2023
Recruitment status
Completed
Enrollment listed in the registry
383
Sponsor
Neumora Therapeutics, Inc.
Sponsor type
Biotech company
Study type
Drug
Intervention type
Drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United States
Age range
From 18 Years to 65 Years
Official registry ID
NCT06029426
Official title
Show the full official title

A Phase 3, Randomized, Double Blind, Placebo Controlled Study to Evaluate the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive Disorder

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Huntsville · Phoenix · Bentonville

56 more locations
  • Little Rock
  • Rogers
  • Bellflower
  • Garden Grove
  • Glendale
  • Imperial
  • Lafayette
  • Long Beach
  • Los Angeles
  • Oceanside
  • Orange
  • Riverside
  • San Jose
  • Sherman Oaks
  • Temecula
  • Torrance
  • Colorado Springs
  • Gainesville
  • Hallandale
  • Jacksonville
  • Lauderhill
  • Maitland
  • Miami
  • Miami Lakes
  • Orlando
  • Tampa
  • Marietta
  • Chicago
  • Evanston
  • Warrenville
  • Boston
  • Methuen
  • Watertown
  • Bloomfield Hills
  • Flowood
  • Saint Charles
  • Las Vegas
  • Brooklyn
  • Cedarhurst
  • New York
  • Staten Island
  • Cleveland
  • Columbus
  • Dayton
  • Garfield Heights
  • Allentown
  • Media
  • Plymouth Meeting
  • Memphis
  • Austin
  • Dallas
  • Houston
  • Wichita Falls
  • Charlottesville
  • Bellevue
  • Everett

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

What did researchers investigate?

Researchers compared NMRA-335140 and placebo to find out how the approaches affected depression symptoms in people with depression.

Who is behind this study?

The study sponsor is Neumora Therapeutics, Inc.

Did this study involve medication?

Yes. The study involved medication, including NMRA-335140 and Placebo.

Who was this study for?

This study was for people with depression. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.

Want to explore more studies?

Explore studies